Conclusion: The decreased levels of MAGP-1 in patients with obesity and CC together with its capacity to modulate key genes involved in ECM remodelling and tumorigenesis suggest MAGP-1 as a link between AT excess and obesity-associated CC development. The gene discussed is MFAP2; the disease is obesity due to melanocortin 4 receptor deficiency.